CPMD OTC
CannaPharmaRX, Inc.
1W: +0.0%
1M: -16.7%
3M: -16.7%
YTD: -77.3%
1Y: -33.3%
3Y: -80.0%
5Y: -94.3%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±8.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$2M
+25.4% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$2M
+27.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2K
+190.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$20M | -$9M | -$9M | $4M | -$10M |
| Depreciation & Amort. | $129K | $3K | $295K | $128K | $0 |
| Stock-Based Comp. | $820K | $363K | $181K | $0 | $0 |
| Change in Working Capital | $4M | -$421K | $4M | -$821K | $24K |
| Other Non-Cash Items | $3M | $2M | $1M | -$5M | $8M |
| Operating Cash Flow | -$564K | -$2M | -$1M | -$2M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$6K | -$116K | -$81K | $0 |
| Acquisitions (Net) | $0 | $539K | $0 | $0 | $0 |
| Investment Purchases | $0 | -$39K | $0 | $0 | $0 |
| Investment Sales | $0 | -$539K | $0 | $0 | $0 |
| Other Investing | $0 | $539K | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $494K | -$116K | -$81K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $12K | $239K | $0 | $0 | $2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $813K | $1M | $968K | $2M | $0 |
| Financing Cash Flow | $825K | $1M | $1M | $2M | $2M |
| Net Change in Cash | $333K | -$307K | -$25K | -$2K | $2K |
| Cash End of Period | $335K | $28K | $2K | $650 | $2K |
| Free Cash Flow | -$564K | -$2M | -$2M | -$2M | -$2M |